SCHEMBL6515586

SCHEMBL6515586

CC(=O)OCC1Cn2c(nc3ccccc32)-c2ccccc2O1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 1/20 0.40
KDM4E B2RXH2 4/20 0.39
HSD17B10 Q99714 4/20 0.39
TSHR P16473 3/20 0.39
TP53 P04637 2/20 0.39
NPC1 O15118 1/20 0.39
PKM P14618 1/20 0.39
RAB9A P51151 1/20 0.39
BRD4 O60885 3/20 0.37
ALDH1A1 P00352 3/20 0.36
HTT P42858 1/20 0.36
MAPK1 P28482 2/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
ESR2 Q92731 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 1/20 0.35
HRH1 P35367 1/20 0.35
PTGIR P43119 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6510656 0.82 KDM4E (0.46) SMN1; SMN2HPGDKDM4EHSD17B10TSHR
SCHEMBL6515650 0.80 PTGS2 (0.42) SMN1; SMN2HPGDKDM4EHSD17B10TSHR
SCHEMBL6518702 0.75 KDM4E (0.49) SMN1; SMN2HPGDKDM4EHSD17B10TSHR
SCHEMBL6520244 0.72 KDM4E (0.46) SMN1; SMN2HPGDKDM4EHSD17B10TSHR
SCHEMBL18427874 0.66 GABRA1 (0.46) HPGDTSHRALDH1A1MAPK1L3MBTL1
SCHEMBL18427875 0.66 GABRA1 (0.46) HPGDTSHRALDH1A1MAPK1L3MBTL1
SCHEMBL6518540 0.66 LMNA (0.43) SMN1; SMN2HPGDKDM4EHSD17B10TSHR
SCHEMBL6520273 0.65 GRM2 (0.39)
SCHEMBL1246139 0.64 KMT2A (0.44) KDM4ENPC1RAB9APOLBMAPT
SCHEMBL6514777 0.64 PIK3CA (0.57) SMN1; SMN2KDM4EHSD17B10TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050239767-A1 Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands NATIONAL SCIENCE FOUNDATION 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239767-A1 Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands TECR, PAICS, DCXR SMN1; SMN2 1768/4885HPGD 890/4885KDM4E 1602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.